Latest News
Hansoh Pharmaceutical Group Company Limited
- Hansoh Pharmaceutical Group Company Limited Estimates – HKEX:3692
- Hansoh Pharmaceutical Group Company Limited News — LSX:A2PLRC
- ADC frenzy continues with $15B+ Roche-Hansoh deal
- Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration
- Roche Collaborates with Hansoh Pharmaceutical to Develop New Drugs in China
- Roche ADC deal could give Hansoh a path to global expansion: Deals Report
- Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion
- Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
- Roche and Hansoh sign cancer drug deal worth over $15 billion
- Hansoh resubmits aumolertinib EU marketing application after data protection revocation
- Hansoh Pharma's Aumolertinib Application Validated by EMA for EU Review
- Hansoh’s overseas ambitions tested as EU stalls cancer drug sales
Headlines from the last 30 days, linking to the original publishers. See all market news →